GSK 2816126

Drug Profile

GSK 2816126

Alternative Names: GSK-2816126

Latest Information Update: 28 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Class Antineoplastics
  • Mechanism of Action EZH2 enzyme inhibitors; Histone modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Diffuse large B cell lymphoma; Follicular lymphoma
  • No development reported Acute myeloid leukaemia

Most Recent Events

  • 28 May 2018 No recent reports of development identified for phase-I development in Diffuse large B cell lymphoma(Second-line therapy or greater) in United Kingdom (IV, Infusion)
  • 28 May 2018 No recent reports of development identified for phase-I development in Diffuse large B cell lymphoma(Second-line therapy or greater) in USA (IV, Infusion)
  • 28 May 2018 No recent reports of development identified for phase-I development in Follicular lymphoma(Second-line therapy or greater) in United Kingdom (IV, Infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top